Harris Todd
President and CEO at TYRA; Head of Corporate Development at Sienna Biopharmaceuticals, Inc.
- Sold, on record
- $9.3M
- Dollars the filings state
- Form 4 sales
- 21
- Latest Oct 21, 2024
- Form 144 notices
- 5
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- TYRATyra Biosciences, Inc.President and CEO
- Sienna Biopharmaceuticals, Inc.Head of Corporate Development
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- TYRA402,175 shares
- Sienna Biopharmaceuticals, Inc.61,075 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice TYRANoticeSep 18, 2024 2024
Filed to sell 15,000 shares ($360k)
Harris Todd, Officer
10b5-1 plan0.8x usual sizeFiling
- 2 Form 144 notice TYRANoticeSep 20, 2024 +2 days
Filed to sell 60,000 shares ($1.4M)
Harris Todd, Officer
10b5-1 plan3x usual sizeFiling
- 3 Form 4 sale TYRARoutineSep 20, 2024 same day
Sold 16,307 shares at $24.19 ($394k)
Harris Todd, President and CEO
10b5-1 planSold 1.1% of holdings ($36.4M position)1.5M shares left0.8x usual sizeFollows a Form 144Filing
- 4 Form 4 sale TYRARoutineSep 25, 2024 +5 days
Sold 11,747 shares at $24.11 ($283k)
Harris Todd, President and CEO
10b5-1 planSold 0.8% of holdings ($35.9M position)1.5M shares left0.6x usual sizeFollows a Form 144Filing
- 5 Form 4 sale TYRARoutineSep 30, 2024 +5 days
Sold 500 shares at $24.00 ($12k)
Harris Todd, President and CEO
10b5-1 planSold 0% of holdings ($35.5M position)1.5M shares left0x usual sizeFollows a Form 144Filing
- 6 Form 144 notice TYRANoticeOct 16, 2024 +16 days
Filed to sell 75,000 shares ($1.8M)
Harris Todd, Officer
10b5-1 plan4.6x usual sizeFiling
- 7 Form 4 sale TYRAUnusualOct 17, 2024 +1 day
Sold 58,726 shares at $25.77 ($1.5M)
Harris Todd, President and CEO
10b5-1 planSold 4% of holdings ($38.1M position)1.4M shares left3.6x usual sizeFollows a Form 144Filing
- 8 Form 4 sale TYRAUnusualOct 21, 2024 +4 days
Sold 62,720 shares at $27.28 ($1.7M)
Harris Todd, President and CEO
10b5-1 planSold 4.4% of holdings ($38.7M position)1.4M shares left3.5x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (26)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2024 | Oct 22, 2024 | TYRA | President and CEO | Form 4 sale | 62,720 | $1.7M | 4.4% | Unusual | SEC |
| Oct 17, 2024 | Oct 17, 2024 | TYRA | President and CEO | Form 4 sale | 58,726 | $1.5M | 4.0% | Unusual | SEC |
| Oct 16, 2024 | Oct 16, 2024 | TYRA | Officer | Form 144 notice | 75,000 | $1.8M | Notice | SEC | |
| Sep 30, 2024 | Oct 2, 2024 | TYRA | President and CEO | Form 4 sale | 500 | $12k | 0.0% | Routine | SEC |
| Sep 25, 2024 | Sep 25, 2024 | TYRA | President and CEO | Form 4 sale | 11,747 | $283k | 0.8% | Routine | SEC |
| Sep 20, 2024 | Sep 20, 2024 | TYRA | President and CEO | Form 4 sale | 16,307 | $394k | 1.1% | Routine | SEC |
| Sep 20, 2024 | Sep 20, 2024 | TYRA | Officer | Form 144 notice | 60,000 | $1.4M | Notice | SEC | |
| Sep 18, 2024 | Sep 18, 2024 | TYRA | Officer | Form 144 notice | 15,000 | $360k | Notice | SEC | |
| Feb 5, 2024 | Feb 6, 2024 | TYRA | President and CEO | Form 4 sale | 100,000 | $1.7M | 6.2% | Unusual | SEC |
| Feb 2, 2024 | Feb 2, 2024 | TYRA | Officer | Form 144 notice | 100,000 | $1.6M | Notice | SEC | |
| Jun 23, 2023 | Jun 26, 2023 | TYRA | Chief Executive Officer | Form 4 sale | 24,190 | $412k | 1.5% | Routine | SEC |
| Jun 21, 2023 | Jun 21, 2023 | TYRA | Chief Executive Officer | Form 4 sale | 75,810 | $1.3M | 4.5% | Unusual | SEC |
| Jun 16, 2023 | Jun 16, 2023 | TYRA | Officer | Form 144 notice | 100,000 | $1.6M | Notice | SEC | |
| Jun 15, 2023 | Jun 15, 2023 | TYRA | Chief Executive Officer | Form 4 sale | 20,700 | $333k | 1.2% | Unusual | SEC |
| Apr 3, 2023 | Apr 5, 2023 | TYRA | Chief Executive Officer | Form 4 sale | 2,000 | $32k | 0.1% | Routine | SEC |
| Mar 31, 2023 | Mar 31, 2023 | TYRA | Chief Executive Officer | Form 4 sale | 4,327 | $70k | 0.3% | No plan | SEC |
| Mar 28, 2023 | Mar 28, 2023 | TYRA | Chief Executive Officer | Form 4 sale | 5,912 | $95k | 0.3% | No plan | SEC |
| Mar 23, 2023 | Mar 23, 2023 | TYRA | Chief Executive Officer | Form 4 sale | 19,236 | $308k | 1.1% | No plan | SEC |
| Apr 30, 2018 | May 2, 2018 | Sienna Biopharmaceuticals, Inc. | Head of Corporate Development | Form 4 sale | 100 | $2k | 0.0% | Plan not stated | SEC |
| Apr 25, 2018 | Apr 25, 2018 | Sienna Biopharmaceuticals, Inc. | Head of Corporate Development | Form 4 sale | 975 | $20k | 0.2% | Plan not stated | SEC |
| Apr 18, 2018 | Apr 19, 2018 | Sienna Biopharmaceuticals, Inc. | Head of Corporate Development | Form 4 sale | 18,011 | $362k | 3.1% | Unusual | SEC |
| Apr 10, 2018 | Apr 12, 2018 | Sienna Biopharmaceuticals, Inc. | Head of Corporate Development | Form 4 sale | 3,779 | $76k | 0.6% | Plan not stated | SEC |
| Apr 9, 2018 | Apr 9, 2018 | Sienna Biopharmaceuticals, Inc. | Head of Corporate Development | Form 4 sale | 8,210 | $164k | 1.4% | Plan not stated | SEC |
| Mar 19, 2018 | Mar 20, 2018 | Sienna Biopharmaceuticals, Inc. | Head of Corporate Development | Form 4 sale | 5,876 | $118k | 1.0% | Plan not stated | SEC |
| Mar 12, 2018 | Mar 14, 2018 | Sienna Biopharmaceuticals, Inc. | Head of Corporate Development | Form 4 sale | 3,452 | $69k | 0.6% | Plan not stated | SEC |
| Mar 9, 2018 | Mar 9, 2018 | Sienna Biopharmaceuticals, Inc. | Head of Corporate Development | Form 4 sale | 20,672 | $414k | 3.3% | Plan not stated | SEC |